Strain-Specific Reduction of Ndel1 Enzymatic Activity During Early Zika Virus Infection in the Neonatal Brain

Technical Summary: Strain-Specific Reduction of Ndel1 Enzymatic Activity During Early Zika Virus Infection in the Neonatal Brain

Problem Statement
Zika virus (ZIKV) infection during early development is causally linked to severe neurodevelopmental impairments, most notably Congenital Zika Syndrome (CZS) and microcephaly. However, the specific molecular mechanisms connecting viral exposure to neuronal dysfunction remain incompletely understood. A critical unresolved question is whether the neuropathogenic effects of flaviviruses represent a conserved host response or if they are driven by virus- and strain-specific interactions. Previous work established that Ndel1 (nudE neurodevelopment protein 1-like 1), an oligopeptidase essential for neuronal migration and cytoskeletal dynamics, exhibits reduced enzymatic activity in ZIKV-infected brains. This study investigates whether such Ndel1 modulation is a general feature of flavivirus infection or a specific signature of the Brazilian ZIKV strain (ZIKVBR), which is uniquely associated with microcephaly, compared to the ancestral African strain (ZIKVAF) and the related Dengue virus (DENV).

Methodology
The researchers utilized a neonatal intracerebroventricular (ICV) infection model in Swiss mice at postnatal day 0 (P0). The study compared three infection groups:

1. ZIKVBR: A Brazilian isolate (strain ZIKV PE/243).
2. ZIKVAF: An African lineage isolate (strain MR766).
3. DENV: Dengue virus.
4. Controls: Mock-infected animals receiving uninfected conditioned medium.

Infection routes included both ICV and intraperitoneal (IP) injections to assess route dependency. Brain tissues were harvested at early post-infection time points (P3 and P7) to analyze:

• Ndel1 Enzymatic Activity: Measured using a fluorogenic FRET substrate (Abz-GFSPFRQ-EDDnp) in brain homogenates.
• Gene Expression: Quantitative RT-qPCR was performed to measure Ndel1 mRNA levels and the expression of inflammatory markers (Il6, Tnf, Il1b) and interferon-pathway genes (Ifnar1, Ifnar2, Ifit1).
• Statistical Analysis: Data were analyzed using Welch's ANOVA, Brown-Forsythe ANOVA, and non-parametric tests (Kruskal-Wallis) where appropriate to account for variance heterogeneity, with post-hoc comparisons against mock controls.

Key Results

1. Strain-Specific Enzymatic Reduction: Ndel1 enzymatic activity was significantly reduced in ZIKVBR-infected animals at both P3 and P7, regardless of the infection route (ICV or IP). In contrast, neither ZIKVAF nor DENV infection resulted in a significant reduction in Ndel1 activity compared to mock controls.
2. Dissociation from Transcriptional Regulation: At P3, the reduction in Ndel1 activity in ZIKVBR-infected brains occurred without a corresponding decrease in Ndel1 mRNA expression. In fact, ZIKVAF infection led to a significant upregulation of Ndel1 mRNA without altering enzymatic activity. Transcriptional downregulation of Ndel1 was only observed at P7, suggesting that functional enzymatic changes precede transcriptional alterations.
3. Independence from Neuroinflammation: Both ZIKVBR and ZIKVAF induced robust neuroinflammatory responses, including significant upregulation of Il6, Tnf, Il1b, and the interferon-stimulated gene Ifit1. Notably, ZIKVAF elicited a stronger inflammatory response than ZIKVBR. Despite these inflammatory differences, only ZIKVBR infection caused Ndel1 downregulation, indicating that the enzymatic reduction is not a secondary consequence of general neuroinflammation or interferon signaling.
4. Route Independence: The specific reduction of Ndel1 activity by ZIKVBR was observed in both ICV and IP infection models, confirming the effect is intrinsic to the viral strain rather than dependent on the method of viral delivery.

Significance and Claims
The paper claims that Ndel1 downregulation is not a universal consequence of flavivirus infection but is a strain-specific molecular signature restricted to the Brazilian ZIKV strain (ZIKVBR). The author posits that this enzymatic dysfunction represents an early molecular event linked to the unique capacity of ZIKVBR to induce microcephaly, distinguishing it from the African strain (ZIKVAF) and DENV, which do not recapitulate this specific neurodevelopmental phenotype.

Key conclusions drawn by the author include:

• Mechanistic Insight: The reduction in Ndel1 activity occurs independently of transcriptional downregulation at early time points and is dissociated from the neuroinflammatory response, suggesting a direct or indirect interaction between ZIKVBR-specific factors and Ndel1 regulatory machinery.
• Biomarker Potential: Ndel1 enzymatic activity serves as a more sensitive and functionally relevant early indicator of ZIKVBR-associated neurodevelopmental impairment than mRNA levels.
• Specificity: The findings support the hypothesis that the neuropathogenicity of ZIKVBR involves specific host-virus interactions distinct from those of other flaviviruses or ZIKV lineages, providing a potential target for early diagnostic biomarkers and neuroprotective strategies.

The author acknowledges limitations, noting that the precise upstream molecular mechanism linking ZIKVBR to Ndel1 modulation remains unresolved and that protein-level quantification was not feasible due to sample constraints. They emphasize that while the findings are robust in the neonatal mouse model, validation in human brain organoids and non-human primate models is required to confirm translational relevance to human Congenital Zika Syndrome.